Abstract
The viability of a programme for delivering aerosolized pentamidine within the patient's home setting for the secondary prophylaxis of Pneumocystis carinii pneumonia (PCP) has been explored with seven homosexual AIDS patients, the major objectives being the assessment of the safety and acceptability of the treatment and the discovery of the most suitable care setting (home, ward, outpatient clinic) for the administration of therapy. It is concluded that a domiciliary prophylaxis programme is a viable alternative.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Conte J. E., Jr, Hollander H., Golden J. A. Inhaled or reduced-dose intravenous pentamidine for Pneumocystis carinii pneumonia. A pilot study. Ann Intern Med. 1987 Oct;107(4):495–498. doi: 10.7326/0003-4819-107-4-495. [DOI] [PubMed] [Google Scholar]
- Montgomery A. B., Debs R. J., Luce J. M., Corkery K. J., Turner J., Brunette E. N., Lin E. T., Hopewell P. C. Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet. 1987 Aug 29;2(8557):480–483. doi: 10.1016/s0140-6736(87)91794-6. [DOI] [PubMed] [Google Scholar]
- O'Doherty M. J., Thomas S., Page C., Barlow D., Bradbeer C., Nunan T. O., Bateman N. T. Differences in relative efficiency of nebulisers for pentamidine administration. Lancet. 1988 Dec 3;2(8623):1283–1286. doi: 10.1016/s0140-6736(88)92894-2. [DOI] [PubMed] [Google Scholar]
- Simonds A. K., Newman S. P., Johnson M. A., Talaee N., Lee C. A., Clarke S. W. Aerosolised pentamidine. Lancet. 1989 Jan 28;1(8631):221–222. doi: 10.1016/s0140-6736(89)91240-3. [DOI] [PubMed] [Google Scholar]